Functional and structural studies of the SARS-CoV-2 accessory protein Nsp8 for novel antiviral therapies

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2020
    2022
  • Known Financial Commitments (USD)

    $460,361.66
  • Funder

    Academy of Finland
  • Principal Investigator

    Matjaz Barboric
  • Research Location

    Finland
  • Lead Research Institution

    University of Helsinki
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Pathogen morphology, shedding & natural history

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

The lack of therapies for COVID-19 calls for detailed studies of the life cycle of SARS-CoV-2, the disease's causative agent. Recent studies have revealed how the virus could reshape the host cell and interact with cellular proteins for optimal replication. Intriguingly, an essential viral accessory protein Nsp8 interacts with LARP7 and MePCE proteins that play important gene regulatory roles in human cells, potentially explaining how the virus rewires the cells and hides from our immune system. We will use multi-disciplinary approaches to shed a light on this important biology of SARS-CoV-2. We shall also solve the three-dimensional structure of Nsp8 bound to LARP7, and identify compounds that interfere with this interaction. In conclusion, our studies shall reveal how SARS-CoV-2 manipulates human cells for its own benefit. Moreover, they shall yield compounds blocking viral replication, paving the way to the urgently needed COVID-19 therapeutics.